Dashboard
Manage Tickers

CRVOCervoMed Inc.

Nasdaq www.cervomed.com


$ 24.47 $ 0.76 (3.18 %)    

Friday, 10-May-2024 15:53:21 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 24.66
$ 24.15
$ 0.00 x 0
$ 0.00 x 0
$ 23.41 - $ 24.92
$ 4.28 - $ 26.38
13,574
na
152.16M
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-29-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-24-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-18-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-17-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-07-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-17-2020 12-31-2019 10-K
18 11-08-2019 09-30-2019 10-Q
19 08-08-2019 06-30-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 03-19-2019 12-31-2018 10-K
22 11-13-2018 09-30-2018 10-Q
23 08-10-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 04-02-2018 12-31-2017 10-K
26 11-13-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 03-31-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 03-25-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-12-2015 06-30-2015 10-Q
36 05-11-2015 03-31-2015 10-Q
37 04-03-2015 12-31-2014 10-K
38 11-12-2014 09-30-2014 10-Q
39 08-14-2014 06-30-2014 10-Q
40 05-20-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

disney-to-rally-around-10-here-are-10-top-analyst-forecasts-for-monday
Disney To Rally Around 10%? Here Are 10 To...
04/08/2024 12:00:36

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

canaccord-genuity-maintains-buy-on-cervomed-raises-price-target-to-65
Canaccord Genuity Maintains Buy on CervoMe...
04/08/2024 11:37:59

Canaccord Genuity analyst Sumant Kulkarni maintains CervoMed (NASDAQ:CRVO) with a Buy and raises the price target from $50 t...

cervomed-announces-private-placement-financing-including-50m-financing-upfront-with-up-to-an-additional-994m-tied-to-exercise-of-warrants
CervoMed Announces Private Placement Finan...
03/28/2024 12:35:08

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
03/21/2024 17:31:11

cervomed-announces-presentation-of-biomarker-data-from-the-ascend-lb-phase-2a-trial-and-preclinical-data-supporting-potential-of-neflamapimod-in-tau-mediated-disease-at-adpd--2024
CervoMed Announces Presentation Of Biomark...
03/05/2024 13:01:13

- Neflamapimod led to significant reduction compared to placebo in plasma levels of glial fibrillary acidic protein (GFAP) - Ne...

canaccord-genuity-initiates-coverage-on-cervomed-with-buy-rating-announces-price-target-of-50
Canaccord Genuity Initiates Coverage On Ce...
02/15/2024 12:18:23

Canaccord Genuity analyst Sumant Kulkarni initiates coverage on CervoMed (NASDAQ:CRVO) with a Buy rating and announces Price...

cervomed-publishes-results-from-ascend-lb-phase-2a-trial-evaluating-treatment-of-neflamapimod-in-dementia-with-lewy-bodies
CervoMed Publishes Results From AscenD-LB ...
02/12/2024 13:08:03

-Integrated summary of all previously published Phase 2a clinical results, together with the first peer reviewed publication of...

cervomed-appoints-joshua-boger-as-board-chair
CervoMed Appoints Joshua Boger As Board Chair
02/07/2024 13:35:27

Dr. Boger is the founder, and retired CEO and Board Chair, of Vertex Pharmaceuticals CervoMed on track to complete enrollment i...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
11/06/2023 13:06:45

cervomed-announced-oral-presentation-at-ctad-2023-highlighting-learnings-from-phase-2a-which-optimized--design-of-phase-2b-clinical-study-of-neflamapimod-in-dementia-with-lewy-bodies
CervoMed Announced Oral Presentation At CT...
10/25/2023 18:51:37

CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain,...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
10/20/2023 21:31:30

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
09/07/2023 17:31:10

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
09/07/2023 13:06:05

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
08/31/2023 21:31:53

ai-eipp-holdings-llc-reports-999-passive-stake-in-cervomed-inc-as-of-aug-16
AI EIPP Holdings Llc Reports 9.99% Passive...
08/28/2023 20:08:03

-SEC Filing

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
08/18/2023 17:31:10

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
08/18/2023 13:06:08

cervomed-shares-begin-trading-on-nasdaq-following-completion-of-merger-of-diffusion-pharma-and-eip-pharma
Cervomed Shares Begin Trading On Nasdaq Fo...
08/17/2023 11:46:33

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION